Roy Buchanan
Stock Analyst at JMP Securities
(0)
# 4762
Out of 5,345 analysts
70
Total ratings
36.21%
Success rate
-20.74%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CVAC CureVac | Reiterates: Market Outperform | 10 10 | 4.47 | 123.71% | 9 | May 28, 2025 | |
CDTX Cidara Therapeutics | Reiterates: Market Outperform | 47 47 | 23 | 104.35% | 4 | May 27, 2025 | |
DVAX Dynavax Technologies | Maintains: Market Outperform | 33 31 | 9.59 | 223.25% | 6 | May 7, 2025 | |
ANTX AN2 Therapeutics | Maintains: Market Outperform | 5 2 | 1.18 | 69.49% | 9 | May 5, 2025 | |
INO Inovio Pharmaceutica... | Reiterates: Market Outperform | 18 18 | 2 | 800% | 3 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 7 4 | 0.84 | 376.19% | 3 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 21 21 | 5.88 | 257.14% | 12 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 23 14 | 0.6 | 2233.33% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 33 33 | 5.71 | 477.93% | 1 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 24 7 | 1.58 | 343.04% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 4 5 | 3.43 | 45.77% | 5 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 3 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 443 448 | 573.21 | -21.84% | 2 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 14 16 | 12.52 | 27.8% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Outperform | 420 | 2.52 | 16566.67% | 1 | Sep 14, 2021 |